Release Date: 23/08/19 16:12 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 408.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%